003220.KS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 02:30):

Stats
Today's Volume	444 034
Average Volume	88 076.00
Market Cap	320.91B
EPS	KRW0 ( 2024-03-14 )
Next earnings date	( KRW428.46 ) 2024-05-13
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW37.12 (0.25%)

Volume Correlation

Long: 0.66 (moderate)

Short: 0.55 (weak)

Signal:(52.462) Neutral

Daewon Pharmaceutical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Daewon Pharmaceutical Correlation - Currency/Commodity

0.06
( neutral )

-0.12
( neutral )

-0.22
( neutral )

0.27
( neutral )

-0.06
( neutral )

0.15
( neutral )

Daewon Pharmaceutical Financials

Annual	2023
Revenue:	KRW526.95B
Gross Profit:	KRW254.23B (48.25 %)
EPS:	KRW1 139.91

Q4	2023
Revenue:	KRW140.85B
Gross Profit:	KRW69.41B (49.28 %)
EPS:	KRW35.36

Q3	2023
Revenue:	KRW128.98B
Gross Profit:	KRW60.01B (46.53 %)
EPS:	KRW260.15

Q2	2023
Revenue:	KRW133.03B
Gross Profit:	KRW65.50B (49.24 %)
EPS:	KRW385.30

Financial Reports:

No articles found.

Daewon Pharmaceutical

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 45 countries primarily in Asia, Central and South America, the Middle East, etc. The company was founded in 1958 and is headquartered in Seoul, South Korea.